| MRIBX | VTSNX | MRIBX / VTSNX | |
| Total Expense Ratio | 1.74 | 0.06 | 2,900% |
| Annual Report Gross Expense Ratio | 1.75 | 0.06 | 2,917% |
| Fund Existence | 28 years | 16 years | - |
| Gain YTD | 10.106 | 15.253 | 66% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.8B | 652B | 3% |
| Annual Yield % from dividends | 0.53 | 2.65 | 20% |
| Returns for 1 year | 14.15 | 29.79 | 48% |
| Returns for 3 years | 31.92 | 53.56 | 60% |
| Returns for 5 years | 25.43 | 39.48 | 64% |
| Returns for 10 years | 103.41 | 109.47 | 94% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSBAX | 20.02 | 0.53 | +2.72% |
| Goldman Sachs Small Cap Growth C | |||
| EMGNX | 43.93 | 1.01 | +2.35% |
| Allspring Emerging Markets Equity Inst | |||
| RNEBX | 107.53 | 1.57 | +1.48% |
| American Funds New World R2E | |||
| NWQFX | 41.65 | 0.51 | +1.24% |
| Nuveen Small/Mid Cap Value R6 | |||
| NGRRX | 40.22 | 0.15 | +0.37% |
| Nuveen International Value I | |||